touchpodcast

touchPODCAST

Science EN ↓ 546 episodes

Welcome to touchPODCAST where you can listen and learn from our expert faculty, hand-picked from the Touch Medical Media family of independent medical websites. Educating physicians on a fully global scale since 2005!We make positive changes to clinical practice, with the ultimate objective of improving patient and community health. Working alongside leading medical experts, societies and industry, our mission is to provide practical, expert opinions to support best practices for busy Healthcare Professionals globally, by translating published data into easily digestible and timely updatesHome...

Author

touchpodcast

Category

Science

Podcast website

touchpodcast.podbean.com

Latest episode

Jul 9, 2026

Where to listen?

Podcasts in the app Replaio Radio Coming soon

Podcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts

Get it on Google Play Install for free Android 5M+ downloads · 4.8 rating iOS soon

Episodes

Emerging second-line treatment approaches in advanced NSCLC: The role of ADCs 22.02.2024

touchTALKS for touchONCOLOGY Listen to a leading expert in lung cancer discuss the role of antibody–drug conjugates (ADCs) in the treatment of patients with advanced non-small cell lung cancer, including their structure and mechanistic rationale, the latest clinical trial data and the optimal management of patients receiving ADCs. The expert Dr Rebecca Heist – Massachusetts General Hospital, Bosto...

Expert insights in food allergy: Considerations for diagnosis and management in primary care and beyond 21.02.2024

touchFOCUS for touchIMMUNOLOGY Listen to Dr Antonella Cianferoni as she answers a series of questions on the diagnosis and management of food allergies. The expert Dr Antonella Cianferoni - Children’s Hospital of Philadelphia, PA, USA This touchPODCAST is for HCPs only. This activity is funded by an independent medical education grant from Thermo Fisher Scientific. This activity is jointly provide...

Expert insights in food allergy: Considerations for diagnosis and management in primary care and beyond 21.02.2024

touchFOCUS for touchRESPIRATORY Listen to Dr Antonella Cianferoni as she answers a series of questions on the diagnosis and management of food allergies. The expert Dr Antonella Cianferoni - Children’s Hospital of Philadelphia, PA, USA This touchPODCAST is for HCPs only. This activity is funded by an independent medical education grant from Thermo Fisher Scientific. This activity is jointly provid...

Emerging second-line treatment approaches in advanced NSCLC: The role of ADCs 21.02.2024

touchTALKS for touchRESPIRATORY Listen to a leading expert in lung cancer discuss the role of antibody–drug conjugates (ADCs) in the treatment of patients with advanced non-small cell lung cancer, including their structure and mechanistic rationale, the latest clinical trial data and the optimal management of patients receiving ADCs. The expert Dr Rebecca Heist – Massachusetts General Hospital, Bo...

Addressing the diagnosis and management of pet allergies in primary care and beyond 14.02.2024

touchFOCUS for touchRESPIRATORY Dr Ann-Marie Schoos answers a series of questions on the diagnosis and management of pet allergies, including the role of component-resolved diagnostics in providing a detailed analysis of patients' sensitization profiles to allow for a more personalized approach to management. The expert: Dr Ann-Marie Schoos - University of Copenhagen, Denmark This touchPODCAST is...

Addressing the diagnosis and management of pet allergies in primary care and beyond 09.02.2024

touchFOCUS for touchIMMUNOLOGY Dr Ann-Marie Schoos answers a series of questions on the diagnosis and management of pet allergies, including the role of component-resolved diagnostics in providing a detailed analysis of patients' sensitization profiles to allow for a more personalized approach to management. The expert: Dr Ann-Marie Schoos - University of Copenhagen, Denmark This touchPODCAST is f...

The rationale for protein degradation and immunomodulation in RRMM: Highlighting the latest data and available clinical trials 09.02.2024

touchEXPERT OPINIONS for touchHAEMATOLOGY Three internationally renowned multiple myeloma experts share insights into the unmet treatment needs for patients with relapsed/refractory multiple myeloma, the rationale for emerging protein degradation and immunomodulation-based therapies, and the latest data and ongoing clinical trials for these investigational agents.   The experts Prof. Cristina Gasp...

The rationale for protein degradation and immunomodulation in RRMM: Highlighting the latest data and available clinical trials 09.02.2024

touchEXPERT OPINIONS for touchONCOLOGY Three internationally renowned multiple myeloma experts share insights into the unmet treatment needs for patients with relapsed/refractory multiple myeloma, the rationale for emerging protein degradation and immunomodulation-based therapies, and the latest data and ongoing clinical trials for these investigational agents.   The experts Prof. Cristina Gaspare...

Diagnosing and treating patients with EoE: Tackling the difficulties 07.02.2024

touchEXPERT OPINIONS for touchIMMUNOLOGY Three experts discuss the challenges related to recognizing, diagnosing and treating patients with eosinophilic oesophagitis (EoE) and highlight how advances in diagnostic tools and emerging treatments may impact future care. The experts: Dr Efrem Eren, Southampton General Hospital, UK Dr Nirmala Gonsalves, Northwestern University Feinberg School of Medicin...

Diagnosing and treating patients with EoE: Tackling the difficulties 07.02.2024

touchEXPERT OPINIONS for touchRESPIRATORY Three experts discuss the challenges related to recognizing, diagnosing and treating patients with eosinophilic oesophagitis (EoE) and highlight how advances in diagnostic tools and emerging treatments may impact future care. The experts: Dr Efrem Eren, Southampton General Hospital, UK Dr Nirmala Gonsalves, Northwestern University Feinberg School of Medici...

touchMDT – Patient-centric care for prurigo nodularis – Discussion 3 06.02.2024

touchMDT for touchIMMUNOLOGY Listen to expert and patient perspectives on the importance of a holistic, multidisciplinary approach in establishing optimal treatment and care pathways for patients with prurigo nodularis. The multidisciplinary team Dermatologist: Prof. Martin Mertz, Berlin, Germany Dermatologist: Dr Manuel Pereira, Berlin, Germany Psychodermatologist: Prof. Anthony Bewley, London, U...

touchMDT – Management of prurigo nodularis – Discussion 2 06.02.2024

touchMDT for touchIMMUNOLOGY Listen to expert perspectives on the current and emerging treatment landscape for prurigo nodularis. The multidisciplinary team Dermatologist: Prof. Martin Mertz, Berlin, Germany Dermatologist: Dr Manuel Pereira, Berlin, Germany Psychodermatologist: Prof. Anthony Bewley, London, UK This touchPODCAST is for HCPs only. This activity is funded by an unrestricted independe...

touchMDT – Burden of prurigo nodularis – Discussion 1 06.02.2024

touchMDT for touchIMMUNOLOGY Listen to expert and patient perspectives on the burden and unmet clinical needs associated with prurigo nodularis. The multidisciplinary team Dermatologist: Prof. Martin Mertz, Berlin, Germany Dermatologist: Dr Manuel Pereira, Berlin, Germany Psychodermatologist: Prof. Anthony Bewley, London, UK Patient advocate: Ms Sailaja Maganti, London, UK This touchPODCAST is for...

touchMDT – Patient-centric care for prurigo nodularis – Discussion 3 06.02.2024

touchMDT for touchDERMATOLOGY Listen to expert and patient perspectives on the importance of a holistic, multidisciplinary approach in establishing optimal treatment and care pathways for patients with prurigo nodularis. The multidisciplinary team Dermatologist: Prof. Martin Mertz, Berlin, Germany Dermatologist: Dr Manuel Pereira, Berlin, Germany Psychodermatologist: Prof. Anthony Bewley, London,...

touchMDT – Management of prurigo nodularis – Discussion 2 06.02.2024

touchMDT for touchDERMATOLOGY Listen to expert perspectives on the current and emerging treatment landscape for prurigo nodularis. The multidisciplinary team Dermatologist: Prof. Martin Mertz, Berlin, Germany Dermatologist: Dr Manuel Pereira, Berlin, Germany Psychodermatologist: Prof. Anthony Bewley, London, UK This touchPODCAST is for HCPs only. This activity is funded by an unrestricted independ...

touchMDT – Burden of prurigo nodularis – Discussion 1 06.02.2024

touchMDT for touchDERMATOLOGY Listen to expert and patient perspectives on the burden and unmet clinical needs associated with prurigo nodularis. The multidisciplinary team Dermatologist: Prof. Martin Mertz, Berlin, Germany Dermatologist: Dr Manuel Pereira, Berlin, Germany Psychodermatologist: Prof. Anthony Bewley, London, UK Patient advocate: Ms Sailaja Maganti, London, UK This touchPODCAST is fo...

Is HER2 targeting on the horizon for urothelial carcinoma? 24.01.2024

touchFOCUS for touchONCOLOGY A genitourinary medical oncologist considers the potential for targeting HER2 in the treatment of urothelial carcinoma, including the rationale for HER2 as a target, approaches to HER2 testing, the latest data on emerging HER2-targeted therapies and the potential implications for future clinical practice.  The expert: Dr Vadim Koshkin - University of California San Fra...

Addressing challenges in diagnosis and treatment of IgG4-related gastrointestinal disease 24.01.2024

touchIN CONVERSATION for touchIMMUNOLOGY Listen to Dr Shounak Majumder (Mayo Clinic, Rochester, MN, USA) in conversation with Professor Matthias Löhr (Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden) on how to optimize the diagnosis and management of patients with IgG4-related gastrointestinal (GI) disease.  They respond to questions from the gastroenterology, hepatolog...

Haemato-oncology experts discuss current considerations and future strategies for CAR T-cell therapies in patients with R/R MCL 10.01.2024

touchIN CONVERSATION for touchONCOLOGY Listen to a conversation between haemato-oncologists Dr Matthew Matasar and Dr Amitkumar Mehta, as they respond to questions submitted by the HCP audience and provide their expert insights on the current considerations and future strategies when managing the practicalities of CAR T-cell therapies in patients with relapsed or refractory mantle cell lymphoma. T...

Haemato-oncology experts discuss current considerations and future strategies for CAR T-cell therapies in patients with R/R MCL 10.01.2024

touchIN CONVERSATION for touchHAEMATOLOGY Listen to a conversation between haemato-oncologists Dr Matthew Matasar and Dr Amitkumar Mehta, as they respond to questions submitted by the HCP audience and provide their expert insights on the current considerations and future strategies when managing the practicalities of CAR T-cell therapies in patients with relapsed or refractory mantle cell lymphoma...

Overcoming challenges in advanced or metastatic squamous cell lung cancer: Focus on immunotherapy 09.01.2024

touchFOCUS for touchONCOLOGY Listen to Dr Balazs Halmos answer a series of questions focused on the distinctive clinical features of squamous cell lung cancer, the challenges they pose to developing a treatment plan, and the role immunotherapy plays in overcoming them.  The expert: Dr Balazs Halmos - Montefiore Einstein Comprehensive Cancer Center, Albert Einstein College of Medicine, Bronx, NY, U...

Overcoming challenges in advanced or metastatic squamous cell lung cancer: Focus on immunotherapy 09.01.2024

touchFOCUS for touchRESPIRATORY Listen to Dr Balazs Halmos answer a series of questions focused on the distinctive clinical features of squamous cell lung cancer, the challenges they pose to developing a treatment plan, and the role immunotherapy plays in overcoming them.  The expert: Dr Balazs Halmos - Montefiore Einstein Comprehensive Cancer Center, Albert Einstein College of Medicine, Bronx, NY...

Haemato-oncology experts discuss managing the practicalities of CAR T-cell therapy in relapsed or refractory follicular lymphoma 08.01.2024

touchIN CONVERSATION for touchONCOLOGY Listen to Dr Nilanjan Ghosh in conversation with Dr Peter Riedell. They respond to questions submitted by the HCP audience and provide their expert insights regarding new horizons in relapsed or refractory follicular lymphoma, with a focus on risk stratification and managing the practicalities of CAR T-cell therapy. This touchPODCAST is for HCPs only. This ac...

Haemato-oncology experts discuss managing the practicalities of CAR T-cell therapy in relapsed or refractory follicular lymphoma 08.01.2024

touchIN CONVERSATION for touchHAEMATOLOGY Listen to Dr Nilanjan Ghosh in conversation with Dr Peter Riedell. They respond to questions submitted by the HCP audience and provide their expert insights regarding new horizons in relapsed or refractory follicular lymphoma, with a focus on risk stratification and managing the practicalities of CAR T-cell therapy. This touchPODCAST is for HCPs only. This...

Advances in IOL technology and power calculations: Updates and innovations 22.12.2023

touchFOCUS for touchOPHTHALMOLOGY Listen to Dr John Hovanesian answer a series of questions focused on how to effectively manage patients prior to cataract surgery and ensure the most appropriate intraocular lens (IOL) formula is used, including his views on recent advances in IOL technology.  The expert: Dr John Hovanesian, University of California, Los Angeles, Jules Stein Eye Institute, CA, USA...

Listen to the touchPODCAST podcast in Replaio

Radio and podcasts in one app - free, with no sign-up. Install today and do not miss the launch

Get it on Google Play

Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.